# OnCo record paper-de-escalate-lancet-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-de-escalate-lancet-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-de-escalate-lancet-2019" ;
  schema:name "De-ESCALaTE HPV: radiotherapy plus cisplatin or cetuximab in low-risk HPV-positive oropharyngeal cancer"@en ;
  schema:description "This European trial, like its American counterpart, found that replacing cisplatin with cetuximab in low-risk HPV-positive oropharyngeal cancer caused more recurrences and deaths without reducing severe toxicity."@en ;
  schema:url <https://onco.cc/key-papers/paper-de-escalate-lancet-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(18)32752-1>, <https://pubmed.ncbi.nlm.nih.gov/30449623/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(18)32752-1> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Mehanna H, Robinson M, Hartley A, et al." ;
  onco:cancers <https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/>, <https://onco.cc/cancers/oropharyngeal-cancer/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:trials <https://onco.cc/trials/de-escalate/> ;
  onco:journals <https://onco.cc/journals/lancet/> .